See more : Solargiga Energy Holdings Limited (0757.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shukra Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- LuxUrban Hotels Inc. 13.00% Series A Cumulative Redeemable Preferred Stock (LUXHP) Income Statement Analysis – Financial Results
- RoboSense Technology Co Ltd (2498.HK) Income Statement Analysis – Financial Results
- Doms Industries Limited (DOMS.BO) Income Statement Analysis – Financial Results
- Pendragon PLC (PDG.L) Income Statement Analysis – Financial Results
- Premium Nickel Resources Ltd. (PNRLF) Income Statement Analysis – Financial Results
Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
About Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 745.73M | 588.34M | 204.86M | 111.96M | 118.46M | 56.60M | 53.44M | 51.37M | 48.25M | 25.76M | 44.31M | 51.61M | 66.33M | 98.63M | 86.34M | 73.40M | 38.19M |
Cost of Revenue | 445.34M | 453.17M | 103.46M | 27.69M | 30.01M | 9.91M | 10.18M | 14.52M | 18.10M | 9.54M | 33.08M | 34.98M | 53.10M | 76.43M | 67.72M | 53.73M | 21.50M |
Gross Profit | 300.39M | 135.17M | 101.40M | 84.27M | 88.45M | 46.69M | 43.26M | 36.85M | 30.16M | 16.21M | 11.23M | 16.63M | 13.23M | 22.19M | 18.62M | 19.67M | 16.69M |
Gross Profit Ratio | 40.28% | 22.97% | 49.50% | 75.26% | 74.66% | 82.50% | 80.95% | 71.74% | 62.49% | 62.95% | 25.34% | 32.23% | 19.94% | 22.50% | 21.57% | 26.80% | 43.71% |
Research & Development | 1.29M | 1.18M | 943.00K | 529.00K | 528.87K | 528.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 525.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 6.75M | 6.01M | 4.31M | 1.89M | 2.30M | 21.78M | 15.64M | 12.12M | 0.00 | 11.94M | 1.47M | 8.07M | 0.00 | 13.82M | 9.92M | 7.90M | 7.00M |
Selling & Marketing | 21.21M | 99.00K | 90.00K | 405.00K | 23.61K | 118.43K | 10.66K | 29.47K | 0.00 | 92.64K | 1.71M | 90.71K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 27.95M | 6.11M | 4.40M | 2.29M | 2.32M | 21.90M | 15.65M | 12.15M | 11.50M | 12.03M | 11.96M | 8.16M | 0.00 | 13.82M | 9.92M | 7.90M | 7.00M |
Other Expenses | 271.62M | 6.97M | 175.00K | 419.00K | 1.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.19M | 1.57M | 5.82M | 11.32M | 10.36M |
Operating Expenses | 300.87M | 99.91M | 89.17M | 81.89M | 87.83M | 39.50M | 33.49M | 26.57M | 26.84M | 14.15M | 18.17M | 45.94M | -7.19M | 15.39M | 15.74M | 19.22M | 17.36M |
Cost & Expenses | 571.70M | 553.08M | 192.63M | 109.58M | 117.84M | 49.40M | 43.67M | 41.09M | 44.94M | 23.69M | 51.25M | 80.91M | 45.92M | 91.82M | 83.46M | 72.95M | 38.86M |
Interest Income | 5.50M | 639.00K | 314.00K | 467.00K | 84.73K | 51.33K | 305.03K | 301.61K | 191.70K | 608.26K | 39.33K | 5.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.76M | 2.56M | 2.81M | 130.00K | 21.00K | 6.22K | 358.31K | 58.15K | 13.71K | 0.00 | 0.00 | 261.75K | 0.00 | 0.00 | 4.26M | 665.84K | 2.08M |
Depreciation & Amortization | 20.50M | 18.38M | 16.62M | 14.74M | 14.78M | 9.63M | 7.37M | 4.66M | 4.48M | 6.00M | 7.79M | 7.29M | 4.46M | 3.20M | 3.67M | 4.25M | 4.33M |
EBITDA | 222.19M | 64.96M | 29.35M | 17.53M | 15.40M | 16.49M | 16.15M | 14.65M | 11.81M | -2.47M | -933.39K | 5.35M | 2.90M | 12.41M | 10.80M | 5.36M | 5.74M |
EBITDA Ratio | 29.79% | 10.37% | 14.30% | 15.90% | 12.15% | 29.14% | 30.23% | 28.51% | 24.47% | -9.58% | -2.11% | 11.14% | 4.37% | 12.58% | 12.51% | 7.30% | 15.04% |
Operating Income | 173.53M | 46.59M | 12.73M | 2.80M | 621.59K | 6.87M | 8.78M | 9.99M | 7.32M | -8.47M | -8.73M | -1.54M | 20.41M | 6.81M | 2.88M | 447.00K | -667.70K |
Operating Income Ratio | 23.27% | 7.92% | 6.21% | 2.50% | 0.52% | 12.13% | 16.44% | 19.44% | 15.18% | -32.88% | -19.69% | -2.98% | 30.78% | 6.90% | 3.33% | 0.61% | -1.75% |
Total Other Income/Expenses | 25.30M | -41.24M | -2.18M | -1.40M | -37.55M | -17.02M | -18.15M | 594.91K | -15.15M | -1.51M | -6.17M | -27.77M | 90.05K | 0.00 | 0.00 | -20.00 | 0.00 |
Income Before Tax | 198.83M | 44.42M | 10.18M | 978.00K | 1.71M | 7.24M | 9.46M | 10.58M | 3.50M | 2.67M | -6.90M | -29.31M | 20.50M | 6.81M | 2.88M | 446.98K | -667.70K |
Income Before Tax Ratio | 26.66% | 7.55% | 4.97% | 0.87% | 1.44% | 12.80% | 17.70% | 20.60% | 7.26% | 10.37% | -15.57% | -56.78% | 30.91% | 6.90% | 3.33% | 0.61% | -1.75% |
Income Tax Expense | 13.46M | 352.00K | 2.67M | -902.00K | 1.35M | 2.62M | 4.20M | 5.55M | 2.31M | 1.36M | 725.35K | 0.00 | 10.97M | 0.00 | 0.00 | 96.42K | 30.00K |
Net Income | 185.37M | 44.07M | 7.51M | 1.88M | 356.04K | 4.62M | 5.26M | 5.03M | 1.19M | 1.31M | -7.68M | -29.31M | 9.54M | 6.81M | 2.88M | 350.56K | -697.70K |
Net Income Ratio | 24.86% | 7.49% | 3.66% | 1.68% | 0.30% | 8.16% | 9.84% | 9.79% | 2.47% | 5.08% | -17.34% | -56.78% | 14.38% | 6.90% | 3.33% | 0.48% | -1.83% |
EPS | 4.23 | 26.21 | 4.79 | 0.25 | 0.05 | 0.74 | 0.84 | 0.80 | 0.19 | 0.21 | -1.23 | -24.76 | 1.68 | 1.20 | 0.51 | 0.06 | -0.12 |
EPS Diluted | 4.23 | 26.21 | 4.79 | 0.25 | 0.05 | 0.74 | 0.84 | 0.80 | 0.19 | 0.21 | -1.23 | -24.76 | 1.68 | 1.20 | 0.51 | 0.06 | -0.12 |
Weighted Avg Shares Out | 43.79M | 1.68M | 1.57M | 7.52M | 7.52M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 1.18M | 5.69M | 5.69M | 5.69M | 5.69M | 5.69M |
Weighted Avg Shares Out (Dil) | 43.79M | 1.68M | 1.57M | 7.52M | 7.52M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 6.26M | 1.18M | 5.69M | 5.69M | 5.69M | 5.69M | 5.69M |
Source: https://incomestatements.info
Category: Stock Reports